Home › PTC Jumps Most Since 2014 as U.K. Regulator Recommends DMD Drug
 

Keywords :   


PTC Jumps Most Since 2014 as U.K. Regulator Recommends DMD Drug

2016-04-16 18:41:20| Biotech - Topix.net

PTC Therapeutics Inc. soared the most since May 2014 after the U.K.'s health-cost regulator recommended its drug for a deadly muscle disease. The U.K.'s National Institute for Health and Care Excellence, known as NICE, recommended PTC's drug Translarna for some patients with Duchenne muscular dystrophy in England, according to a statement Friday.

Tags: drug recommends regulator jumps

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Hurricane Isaac Forecast Advisory Number 10
More »